Behavioral analysis through the lifespan of disc1 mutant zebrafish identifies defects in sensorimotor transformation.

Autor: Pluimer BR; Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA., Harrison DL; Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA., Boonyavairoje C; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Prinssen EP; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland., Rogers-Evans M; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland., Peterson RT; Deparment of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA., Thyme SB; Department of Neurobiology, University of Alabama, Birmingham, AL 35294, USA., Nath AK; Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA.; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.; Broad Institute, Cambridge, MA 02142, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

Publikováno v: IScience [iScience] 2023 Jun 14; Vol. 26 (7), pp. 107099. Date of Electronic Publication: 2023 Jun 14 (Print Publication: 2023).

Evolution of a maternal immune activation (mIA) model in rats: Early developmental effects.

Autor: Murray KN; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester M13 9PT, United Kingdom., Edye ME; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester M13 9PT, United Kingdom., Manca M; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester M13 9PT, United Kingdom., Vernon AC; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, 5 Cutcombe Road, London SE5 9RT, United Kingdom; King's College London, MRC Centre for Neurodevelopmental Disorders, New Hunt's House, Guy's Hospital Campus, London SE1 1UL, United Kingdom., Oladipo JM; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester M13 9PT, United Kingdom., Fasolino V; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester M13 9PT, United Kingdom., Harte MK; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester M13 9PT, United Kingdom., Mason V; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester M13 9PT, United Kingdom., Grayson B; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester M13 9PT, United Kingdom., McHugh PC; Centre for Biomarker Research and Department of Pharmacy, School of Applied Sciences, University of Huddersfield, HD1 3DH, United Kingdom., Knuesel I; Roche Innovation Center Basel, 124 Grenzacherstrasse, Basel, CH 4070, Switzerland., Prinssen EP; Roche Innovation Center Basel, 124 Grenzacherstrasse, Basel, CH 4070, Switzerland., Hager R; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester M13 9PT, United Kingdom. Electronic address: Reinmar.Hager@manchester.ac.uk., Neill JC; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester M13 9PT, United Kingdom. Electronic address: joanna.neill@manchester.ac.uk.

Publikováno v: Brain, behavior, and immunity [Brain Behav Immun] 2019 Jan; Vol. 75, pp. 48-59. Date of Electronic Publication: 2018 Sep 12.

Effect of acetaminophen use on GABA, NMDA, and synaptic plasticity-related genes in the immature mouse brain: A preliminary study.

Autor: Göl, Mehmet Fatih¹ (AUTHOR) m-fatih-gol@hotmail.com, Erdoğan, Füsun Ferda² (AUTHOR), Baydemir, Recep² (AUTHOR), Gök, Duygu Kurt¹ (AUTHOR), Taheri, Serpil^3,4 (AUTHOR), Önal, Müge Gülcihan^3,4 (AUTHOR), Şükranlı, Zeynep Yılmaz³ (AUTHOR), Güvenilir, Ecma^3,4 (AUTHOR), Yora, Samed³ (AUTHOR)

Publikováno v: EuroBiotech Journal. Oct2024, Vol. 8 Issue 4, p122-133. 12p.

Characterization of the Discriminative Stimulus Effects of a NOP Receptor Agonist Ro 64-6198 in Rhesus Monkeys.

Autor: Saccone PA; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (P.A.S., K.A.Z., A.M.L., J.H.W.); National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland (A.S., K.C.R.); and Hoffman- La Roche Ltd., Basel, Switzerland (E.P.P., J.W.) sacconep@umich.edu., Zelenock KA; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (P.A.S., K.A.Z., A.M.L., J.H.W.); National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland (A.S., K.C.R.); and Hoffman- La Roche Ltd., Basel, Switzerland (E.P.P., J.W.)., Lindsey AM; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (P.A.S., K.A.Z., A.M.L., J.H.W.); National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland (A.S., K.C.R.); and Hoffman- La Roche Ltd., Basel, Switzerland (E.P.P., J.W.)., Sulima A; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (P.A.S., K.A.Z., A.M.L., J.H.W.); National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland (A.S., K.C.R.); and Hoffman- La Roche Ltd., Basel, Switzerland (E.P.P., J.W.)., Rice KC; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (P.A.S., K.A.Z., A.M.L., J.H.W.); National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland (A.S., K.C.R.); and Hoffman- La Roche Ltd., Basel, Switzerland (E.P.P., J.W.)., Prinssen EP; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (P.A.S., K.A.Z., A.M.L., J.H.W.); National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland (A.S., K.C.R.); and Hoffman- La Roche Ltd., Basel, Switzerland (E.P.P., J.W.)., Wichmann J; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (P.A.S., K.A.Z., A.M.L., J.H.W.); National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland (A.S., K.C.R.); and Hoffman- La Roche Ltd., Basel, Switzerland (E.P.P., J.W.)., Woods JH; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (P.A.S., K.A.Z., A.M.L., J.H.W.); National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland (A.S., K.C.R.); and Hoffman- La Roche Ltd., Basel, Switzerland (E.P.P., J.W.).

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2016 Apr; Vol. 357 (1), pp. 17-23. Date of Electronic Publication: 2016 Jan 22.

Can 5-HT3 antagonists contribute toward the treatment of schizophrenia?

Autor: Ellenbroek BA; aSchool of Psychology, Victoria University of Wellington, Wellington, New Zealand bRoche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Prinssen EP

Publikováno v: Behavioural pharmacology [Behav Pharmacol] 2015 Feb; Vol. 26 (1-2), pp. 33-44.